Asian Journal of Cardiology Research

Aim: Despite comprehensive management recommendations for ischemic heart disease, the prevalence of ischemic heart disease continues to rise. Similar actions have been observed in various herbal drugs, making them promising targets for developing new therapeutic options for treating ischemic heart disease. The Ischemia Reversal Program addresses this issue by combining Panchakarma with nutrition therapy.

Methods: A retrospective, observational study was conducted at a single center in Maharashtra, India. The study duration was 2018 to 2022. A total of 84 patients aged 18 years and above diagnosed with inducible ischemic heart disease by stress test participated in the Ischemia Reversal Program and were included in the study. Day 1, day 90, and 1 year 1 day data were compared.

Results: Mean age of the study population was 58.83 ± 12.29 years. Males comprised 29 (34.5%) patients of the study population. Mean weight decreased significantly (day 1: 66.43 ± 11.71 kg, day 90: 61.04 ± 9.99 kg, and 1 year 1 day: 61.95 ± 10.92 kg). Body mass index decreased significantly (day1: 25.87 ± 4.55, day 90: 23.84 ± 3.87, 1 year 1 day: 24.12 ± 4.09). Also, Vo2 max increased significantly (day 1: 14.59 ± 6.99, day 90: 25.83 ± 8.47, and 1 year 1 day: 25.46 ± 9.05).

Conclusion: Ayurvedic Panchakarma in the form of the Ischemia Reversal Program showed significant short-term and long-term results in management of patients diagnosed with ischemic heart disease patients.